[1]
K. Skibicka, T. Skibicki, W. Wesołowsla, and J. Pietrzak, “New Pharmacologic Approaches in Hypertension: Baxdrostat and Zilebesiran with Insights from BaxHTN and KARDIA-3 Trials”, J Educ Health Sport, vol. 84, p. 65430, Sep. 2025.